EU – Page 2 – HealthQuill

AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according to a company statement.

FDA approves AstraZeneca’s type-2 diabetes drug in US market

AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according.

by HealthQuill
June 13, 2024
0 Comments

Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus vaccine from CSL Sequris UK Ltd., over a maximum period of four years to prevent the spread or potential outbreaks of bird flu in the region.

Drugs Health Pharma

EU to procure 40 million doses of avian flu vaccine from CSL Seqirus

Fifteen member states of the European Union and the European Economic Area will procure up to 40 million doses of avian influenza virus.

by HealthQuill
June 12, 2024
0 Comments

Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance Minister Bruno Le Maire said, according to a publicly-funded television network, France 24.

Drugs Health Pharma

Pfizer, AstraZeneca to invest close to $1 billion in France to expand

HQ Team May 13, 2024: Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance.

by HealthQuill
May 13, 2024
0 Comments

Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian influenza virus acquires the ability to spread quickly, according to the European Food Safety Authority (EFSA).

Drugs Health Pharma

EFSA issues warning on bird flu spread, says humans lack immunity

HQ Team April 3, 2024: Humans’ lack of immunity may rapidly result in the transmission of bird flu among people if the avian.

by HealthQuill
April 3, 2024
0 Comments

Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to treat nervous system impairment.

Drugs Health Pharma

USFDA clears AstraZeneca-Ionis’ drug for nervous system impairment

HQ Team December 22, 2023: Anglo-Swedish AstraZeneca Inc., and US-based Ionis Pharmaceuticals, announced the FDA has granted its nod for Wainua drug to.

by HealthQuill
December 22, 2023
0 Comments

France has started a vaccination programme for farmed ducks to protect them against highly pathogenic avian influenza (HPAI) inviting a US ban on poultry imports from that country and the EU.

Drugs Health Pharma

France’s decision to vaccinate ducks against HPAI virus invites US ban

HQ Team October 3, 2023: France has started a vaccination programme for farmed ducks to protect them against highly pathogenic avian influenza (HPAI).

by HealthQuill
October 3, 2023
0 Comments

Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market in Asia.

Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

by HealthQuill
September 29, 2023
0 Comments

Thirty-three governments got dragged to the Strasbourg Court by six Portugal adolescents, who argued the states were acting slowly against climate change.

Climate Health Pharma

Strasbourg Court begins hearing on climate charges against 33 nations

HQ Team September 27, 2023: Thirty-three governments got dragged to the Strasbourg Court by six Portugal adolescents, who argued the states were acting.